banner ad

Archive for April, 2010

Orthovita Announces 2010 First Quarter Product Sales

Akillas | April 26, 2010 | 0 Comments

MALVERN, Pa., Apr 22, 2010 (BUSINESS WIRE) — Orthovita, Inc. (VITA 4.24, 0.00, 0.00%) , a leading orthobiologics and biosurgery company, today announced that product sales for the first quarter of 2010 were $24.1 million, an 11% increase over product sales of $21.7 million in the first quarter of 2009. Product sales for the quarter [...]

Continue Reading

NuVasive Reports First Quarter 2010 Financial Results

Akillas | April 26, 2010 | 0 Comments

- Reiterates 2010 Guidance for Revenue and Earnings per Share – – Total revenue of $109.1 million – GAAP earnings of $1.1 million, or $0.03 per share; Non-GAAP earnings of $8.3 million, or $0.21 per share – Operating cash flow of $9.1 million

Continue Reading

Orthofix International Comments on Competitor’s Statements on Investor Call

Akillas | April 26, 2010 | 0 Comments
Orthofix International Comments on Competitor’s Statements on Investor Call

Press Release Source: Orthofix International N.V. On Wednesday April 21, 2010 BOSTON–(BUSINESS WIRE)–Orthofix International N.V. (NASDAQ:OFIX – News) (the Company) today responded to public comments made yesterday by NuVasive, Inc. during their first quarter earnings call stating that a dispute has been initiated against the Company. The comments indicated that the dispute apparently concerns the [...]

Continue Reading

NuVasive Initiates “Legal Dispute” Over Stem Cell IP

Akillas | April 26, 2010 | 0 Comments
NuVasive Initiates “Legal Dispute” Over Stem Cell IP

BY LAUREN UZDIENSKI, APRIL 21, 2010 Yesterday afternoon on their 1Q:10 conference call, NuVasive revealed that they initiated a “legal dispute” against Orthofix over IP related to Osteocel, the stem-cell-based bone graft substitute acquired by NuVasive from Osiris in 2008. The details of this dispute were not revealed, but NuVasive vowed to “aggressively defend” their [...]

Continue Reading